Lenzing AG/ AT0000644505 /
21/06/2024 16:13:00 | Chg. +0.1500 | Volume | Bid22:00:02 | Demandez à22:00:02 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
33.9500EUR | +0.44% | 45 Chiffrre d'affaires: 1,527.7500 |
34.3000Bid taille: 150 | 34.3000Ask la taille: 150 | 1.11 Mrd.EUR | - | - |
GlobeNewswire
17:06
ROSEN, THE FIRST FILING FIRM, Encourages AXT, Inc. Investors to Secure Counsel Before Important Dead...
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page